Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-000229

CEO and CFO bought 4,300 shares at $21.36 ($91,848)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-12-31 Purchase +4,300 $21.36 $91,848 5,599,402 D: show line 1 in the form
Open-market purchases · 4,300 sh · avg $21.36 · $91,848
Loading xslF345X05/ownership.xml…